Eton Pharmaceuticals, Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

24.99

-0.37 (-1.46%)

At close: Apr 2, 2026, 4:00 PM EDT

25.00

+0.01 (0.04%)

After-hours: Apr 2, 2026, 6:40 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Developing and Commercializing Prescription Drug Products	79.95M	39.01M	31.64M	21.25M	21.83M
Developing and Commercializing Prescription Drug Products Growth	104.94%	23.29%	48.90%	-2.66%	55879.49%
Total	79.95M	39.01M	31.64M	21.25M	21.83M
Total Growth	104.94%	23.29%	48.90%	-2.66%	55879.49%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	79.95M	39.01M	31.64M	21.25M	21.83M
United States Growth	104.94%	23.29%	48.90%	-2.66%	55879.49%
Total	79.95M	39.01M	31.64M	21.25M	21.83M
Total Growth	104.94%	23.29%	48.90%	-2.66%	55879.49%

Source: S&P Global Market Intelligence.